Ann B. Nattinger, MD, MPH
Associate Provost for Research; Senior Associate Dean for Research, School of Medicine; Professor of Medicine, Lady Riders Professor of Breast Cancer Research; Principal Investigator, CHDS
- Office of Research
Ann B. Nattinger, MD, MPH, MACP, is Associate Provost for Research; Senior Associate Dean for Research, School of Medicine; Professor of Medicine, Lady Riders Professor of Breast Cancer Research; Principal Investigator, CHDS at the Medical College of Wisconsin in Milwaukee. Dr. Nattinger is a nationally recognized breast cancer health services researcher. She studies variations in cancer treatment and follow-up care, disparities in care by race and socioeconomic status, and cancer survivorship issues. Her work, funded mostly by the National Cancer Institute, has been published in leading journals, such as New England Journal of Medicine, Lancet, and JAMA. As Founding Director of the MCW Center for Patient Care and Outcomes Research (now Center for Advancing Population Science), Dr. Nattinger developed a college-wide interdisciplinary group of health services and disparities researchers. Until 2016, she was Chief of General Internal Medicine. In this capacity, she developed new hospitalist and perioperative programs and led 100 faculty members. As Associate Provost since 2016, she oversees the entire portfolio of research for MCW. She has assisted MCW in developing a comprehensive plan for research growth and innovation. In addition, she leads the research infrastructure, including all related regulatory offices. She is a Master of the American College of Physicians and has served as President of the Society of General Internal Medicine.
Centralization of Initial Care and Improved Survival of Poor Patients With Breast Cancer.
(Nattinger AB, Bickell NA, Schymura MJ, Laud P, McGinley EL, Fergestrom N, Pezzin LE.) J Clin Oncol. 2023 Apr 10;41(11):2067-2075 PMID: 36603178 SCOPUS ID: 2-s2.0-85152169276 01/06/2023
Nursing implications of an early warning system implemented to reduce adverse events: a qualitative study.
(Braun EJ, Singh S, Penlesky AC, Strong EA, Holt JM, Fletcher KE, Stadler ME, Nattinger AB, Crotty BH.) BMJ Qual Saf. 2022 Oct;31(10):716-724 PMID: 35428684 SCOPUS ID: 2-s2.0-85128972108 04/17/2022
Collective Action: The Medical College of Wisconsin COVID-19 Vaccination Program.
(Sanchez AM, Busse K, MacKinnon K, Henk L, MacKinnon GE, Brown J, Mauermann S, Dobrowski T, Jungmann J, Bultman J, Singh S, Nattinger AB.) WMJ. 2021 Dec;120(4):305-308 PMID: 35025179 SCOPUS ID: 2-s2.0-85123461368 01/14/2022
SARS-CoV-2 Cycle Thresholds, Poverty, Race, and Clinical Outcomes.
(Rivera F, Gmehlin CG, Pezzin LE, Hanson R, Perez A, Singh S, Ledeboer NA, Buchan BW, Nattinger AB, Munoz-Price LS.) WMJ. 2021 Dec;120(4):301-304 PMID: 35025178 SCOPUS ID: 2-s2.0-85123460891 01/14/2022
Disparities in utilization of outpatient surgical care among children.
(Powers RJ, Mokdad AA, Pezzin LE, Nattinger AB, Oldham KT, Van Arendonk KJ.) Surgery. 2021 Dec;170(6):1815-1821 PMID: 34167822 SCOPUS ID: 2-s2.0-85109367167 06/26/2021
Letter to the Editor in Response to: Socioeconomic Status and COVID-19 Outcomes.
(Rivera F, Munoz-Price LS, Nattinger AB.) J Gen Intern Med. 2021 Oct;36(10):3238 PMID: 34378114 PMCID: PMC8354303 08/12/2021
Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States.
(Beyer KMM, Zhou Y, Laud PW, McGinley EL, Yen TWF, Jankowski C, Rademacher N, Namin S, Kwarteng J, Beltrán Ponce S, Nattinger AB.) J Clin Oncol. 2021 Sep 01;39(25):2749-2757 PMID: 34129388 PMCID: PMC8407650 SCOPUS ID: 2-s2.0-85115440319 06/16/2021
Association of Inpatient Continuity of Care With Complications and Length of Stay Among Hospitalized Medicare Enrollees.
(Goodwin JS, Li S, Hommel E, Nattinger AB, Kuo YF, Raji M.) JAMA Netw Open. 2021 Aug 02;4(8):e2120622 PMID: 34383060 PMCID: PMC9026593 08/13/2021
Guideline-concordant treatment predicts survival: a National Cancer Database validation study of novel composite locoregional and systemic treatment scores among women with early stage breast cancer.
(Yen TWF, Garacci Z, Laud PW, Pezzin LE, Nattinger AB.) Breast Cancer. 2021 May;28(3):698-709 PMID: 33398775 SCOPUS ID: 2-s2.0-85098792560 01/06/2021
An adapted two-step floating catchment area method accounting for urban-rural differences in spatial access to pharmacies.
(Zhou Y, Beyer KMM, Laud PW, Winn AN, Pezzin LE, Nattinger AB, Neuner J.) J Pharm Health Serv Res. 2021 Mar;12(1):69-77 PMID: 33717229 PMCID: PMC7938828 03/16/2021
Transmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units.
(Khader K, Munoz-Price LS, Hanson R, Stevens V, Keegan LT, Thomas A, Pezzin LE, Nattinger A, Singh S, Samore MH.) Clin Infect Dis. 2021 Jan 29;72(Suppl 1):S1-S7 PMID: 33512524 PMCID: PMC7844587 SCOPUS ID: 2-s2.0-85100683679 01/30/2021
An Adapted Two-Step Floating Catchment Area Method Accounting for Urban-Rural Differences in Spatial Access to Pharmacies
(Zhou Y., Beyer K.M.M., Laud P.W., Winn A.N., Pezzin L. E., Nattinger A.B., Neuner J..) Journal of Pharmaceutical Health Services Research. Zhou, Y., Beyer, K.M.M., Laud, P. W., Winn, A. N., Pezzin, L. E., Nattinger, A. B., Neuner, J. 2021 An Adapted Two-Step Floating Catchment Area Method Accounting for Urban-Rural Differences in Spatial Access to Pharmacies, Journal of Pharmaceutical Health Services Research, 12(1): 69–77. 01/16/2021